Novel concepts in Ca2+ channel selectivity

被引:2
作者
Hermsmeyer, K
Miyagawa, K
机构
[1] OREGON HLTH SCI UNIV, DEPT DEV & CELL BIOL, BEAVERTON, OR USA
[2] OREGON HLTH SCI UNIV, DEPT MED, BEAVERTON, OR USA
[3] OREGON HLTH SCI UNIV, OREGON REG PRIMATE RES CTR, BEAVERTON, OR USA
关键词
T-type; calcium channel; low voltage activated; vascular muscle; cardiac muscle;
D O I
10.1097/00004872-199715033-00002
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Properties of mibefradil Mibefradil produces a unique combination of T-type Ca2+ channel block and protein kinase C inhibition, and thus effective vasodilation, without adverse positive chronotropic or negative inotropic cardiac actions. Lack of reflex sympathetic activation In contrast to virtually every other vasodilator, mibefradil avoids the reflex sympathetic activation and increased heart rate that form the practical limit for existing vasodilator action. The freedom from increased heart rate is especially important for maintaining an adequate blood flow in the coronary circulation. Conclusions Mibefradil offers a new concept in Ca2+ channel antagonism, with long-term protection against the pathophysiological consequences of hypertension.
引用
收藏
页码:S5 / S10
页数:6
相关论文
共 39 条
[1]   PHARMACOLOGY OF CALCIUM CHANNELS IN CARDIAC-MUSCLE, VASCULAR MUSCLE, AND NEURONS [J].
BEAN, BP .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (07) :S406-S411
[2]   CALCIUM CHANNELS IN MUSCLE-CELLS ISOLATED FROM RAT MESENTERIC-ARTERIES - MODULATION BY DIHYDROPYRIDINE DRUGS [J].
BEAN, BP ;
STUREK, M ;
PUGA, A ;
HERMSMEYER, K .
CIRCULATION RESEARCH, 1986, 59 (02) :229-235
[3]   Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967) - A new generation of calcium antagonists? [J].
Bernink, PJLM ;
Prager, G ;
Schelling, A ;
Kobrin, I .
HYPERTENSION, 1996, 27 (03) :426-432
[4]  
BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540
[5]  
Buhler Fritz R., 1995, P2801
[6]   EFFECTS OF RO-40-5967, A NOVEL CALCIUM-ANTAGONIST, ON MYOCARDIAL-FUNCTION DURING ISCHEMIA INDUCED BY LOWERING CORONARY PERFUSION-PRESSURE IN DOGS - COMPARISON WITH VERAPAMIL [J].
CLOZEL, JP ;
BANKEN, L ;
OSTERRIEDER, W .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (05) :713-721
[7]   RO 40-5967 - A NEW NONDIHYDROPYRIDINE CALCIUM-ANTAGONIST [J].
CLOZEL, JP ;
OSTERRIEDER, W ;
KLEINBLOESEM, CH ;
WELKER, HA ;
SCHLAPPI, B ;
TUDOR, R ;
HEFTI, F ;
SCHMITT, R ;
EGGERS, H .
CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (01) :4-17
[8]  
De Gasparo Marc, 1995, P1695
[9]  
FOLKOW B, 1985, HYPERTENSION PATHOPH, P481
[10]  
GODFRAIND T, 1986, PHARMACOL REV, V38, P321